Boundaries between behavioral conditions and medical differentials are likely to blur more rather than less as we learn more about genomic, cellular, and subcellular effects on common conditions. These changes should lead to better treatment but may also require a paradigm shift in how we view behavioral conditions and the mechanisms that contribute to them.